Increasing evidence has revealed that alteration in nutrition metabolism can lead to aberrant O-GlcNAcylation, which directly modifies metabolic enzymes such as PGK1, PFK1, G6PD, PKM2 and MDH1 to reprogram metabolic pathways, thereby contributing to tumor growth [44, 49–52]. The gene discussed is PGK1; the disease is neoplasm.